Abstract:Cardenolide glycosides are natural compounds known to inhibit the ion pumping function of the Na + /K + -ATPase in cellular systems. Interestingly, various cancer cell types are highly susceptible to cardenolide glycosides. Herein, we explore the cardenolide glycoside Acovenoside A (AcoA) with respect to its influences on human A549 non-small cell lung cancer (NSCLC) cells. We found that exposure to AcoA, digoxin and ouabain increases intracellular sodium and ATP levels indicating that the ion pumping function of the transmembrane Na + /K + -ATPase is effectively inhibited. Like digoxin and ouabain, AcoA inhibits transcription factor NF-κB activation and induces apoptotic cell death in NSCLC cells. This was confirmed by a preclinical in vivo model in which AcoA treatment of NSCLC xenografts grown on chick chorioallantoic membranes inhibited the expression of proliferation antigen Ki-67 and induced apoptotic DNA strand breaks. We aimed to elucidate the underlying mechanisms. The Na + /K + -ATPase transmembrane complex contains Src kinase and epidermal growth factor receptor (EGFR). Indeed, we found that AcoA activates Src kinase in A549 cells, but not in a cell-free assay using recombinant Src kinase. Src kinase is a downstream target of EGFR, and correlation analysis using the NCI60 database pointed to a role of EGFR in cardenolide glycoside-induced cancer cell death. Accordingly, NSCLC cells expressing hyperphosphorylated EGFR mut exhibited resistance to AcoA. To investigate the interaction between cardenolide glycosides and EGFR in detail, we performed immunoblotting studies: Whereas ligand binding and EGFR phosphorylation were not significantly affected, ubiquitinated EGFR accumulated after prolonged incubation with AcoA. To visualize EGFR trafficking we used A549 cells transfected with a fluorescent biosensor which binds to activated EGFR. Pretreatment with AcoA and digoxin induced accumulation of EGFR in endosomal compartments thus inhibiting EGF-induced EGFR degradation comparable to the Na + ionophore monensin, a known inducer of EGFR endosomal arrest. Intracellular Na + concentrations regulate EGFR trafficking and signaling. Na + homeostasis is maintained by the Na + /K + -ATPase, which might account for its close interaction with the EGFR. Cardenolide glycosides inhibit the ATP-dependent Na + /K + exchange through the Na + /K + -ATPase resulting in higher intracellular Na + levels. Our data provide first evidence that this impedes efficient EGFR trafficking at the endosomal compartment.

Negative regulation of thyroid adenoma-associated protein (THADA) in the cardiac glycoside-induced anti-cancer effect

Lanatoside C, a cardiac glycoside, acts through protein kinase Cδ to cause apoptosis of human hepatocellular carcinoma cells

Cardiac glycosides inhibit cancer through Na/K-ATPase-dependent cell death induction.

THADA inhibits autophagy and increases 5-FU sensitivity in gastric cancer cells via the PI3K/AKT/mTOR signaling pathway

Targeting Na+/K+‐translocating Adenosine Triphosphatase in Cancer Treatment

Digoxin and its Na+/K+-ATPase-targeted actions on cardiovascular diseases and cancer

Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment.

Lanatoside C Induces G2/M Cell Cycle Arrest and Suppresses Cancer Cell Growth by Attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR Signaling Pathways

Na+/K+-ATPase-Targeted Cytotoxicity of (+)-Digoxin and Several Semisynthetic Derivatives

Structural Insights into the Interactions of Digoxin and Na+/K+-ATPase and Other Targets for the Inhibition of Cancer Cell Proliferation

Cardiac Glycosides Initiate Apo2l/Trail-Induced Apoptosis in Non-Small Cell Lung Cancer Cells by Up-Regulation of Death Receptors 4 and 5

Inhibition of the Na+/K+-ATPase by cardiac glycosides suppresses expression of the IDO1 immune checkpoint in cancer cells by reducing STAT1 activation

Toxicarioside A Inhibits Tumor Growth And Angiogenesis: Involvement Of Tgf-Beta/Endoglin Signaling

Digoxin and Other Cardiac Glycosides Inhibit HIF-1α Synthesis and Block Tumor Growth

Knockdown of GATAD2A Suppresses Cell Proliferation in Thyroid Cancer in Vitro

LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer

Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation and proteasomal degradation

Cardiac Glycosides Inhibit Proliferation And Induce Apoptosis Of Human Hematological Malignant Cells

Effect of Lactate Export Inhibition on Anaplastic Thyroid Cancer Growth and Metabolism

THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy

The Cardenolide Glycoside Acovenoside A Interferes with Epidermal Growth Factor Receptor Trafficking in Non-Small Cell Lung Cancer Cells